Transpharmation Logo
  • Contact Us

Models & Assays

Using the ARTE10 (APP-PS1) Mouse Model at 5 Months (In Collaboration with Taconic Biosciences)

Early Alzheimer’s Biomarkers: Using the ARTE10 (APP-PS1) Mouse Model at 5 Months

In Collaboration with Taconic Biosciences

The ARTE10 double transgenic mouse model, which expresses mutant forms of human APP (Swedish mutation) and human Presenilin 1 carrying the M146 mutation (PSEN1), serves as a translational preclinical model for studying Alzheimer's disease. Despite its potential, there is limited data available on various behavioral assays and relevant biomarkers across different time points in the ARTE10 model.

Our aim is to behaviorally and biochemically characterize the ARTE10 model across three time points, corresponding to early, middle, and late stages of amyloid progression. Currently, we present data from the first time point at 5 months of age.

At 5 months of age, ARTE10 mice exhibit increased anxiety-like behaviors, hyperactivity, deficits in sensory motor gating, and spatial working memory deficits. Additionally, these mice show biomarkers relevant to Alzheimer's disease, including increased amyloid load in the hippocampus and cortex, and trending differences in NfL and cytokines. Data at 10 months of age is coming soon!

Sensory motor gating- Prepulse inhibition (PPI)

Start Amplitudes All dB Prepulses

Homozygous ARTE10 animals have an increased startle response and reduced PPI indicating deficits in sensory motor-gating compared to WT controls

Anxiety-like Behavior - Canopy Test

Anxiety-like behaviours are detected in homozygous ARTE10 animals at 5 months of age using the canopy test1. ARTE10 animals also perform less risk-taking behaviours such as looking over the edge of the canopy maze.

Arena figure
Time spent under canopy Distance Travelled (Open Zone) # of Stretch Attends # of Looks Over the Edge

Well-being-like Behavior - Nest Building

Nest complexity is indicative of an animal’s mood, motivation and well-being. ARTE10 animals do not build nests as complex as WT controls supporting a mood disturbance in these animals2.

1
Nest 1
3
Nest 2
5
Nest 3
Nest Building

Motor Function - Locomotor Activity (LMA)

Hypolocomotion in ARTE10 mice, is likely due to increased anxiety-like behavior in a novel environment. Animals prefer the outer edges and corners compared to the open center as shown in the path plots.

Distance Travelled ARTE10 Distance Travelled ARTE10 (Time Bins) Ambulatory Episodes ARTE10 Rearing Counts ARTE10
WT
WT
ARTE10
ARTE10

Motor Function – Rotarod

ARTE10 animals show no motor function deficits using the rotarod at 5 months of age.

Rotarod - 5 month

Motor Function - Running Wheel (20 hour recordings)

The running wheel provides information about natural activity levels during the animal's dark and light phases. ARTE10 mice are naturally hyperactive in the running wheel. This data supports the hypothesis that LMA hypoactivity may be anxiety related.

Running Wheel - Day 1 Running Wheel - Day 2 Running Wheel - Day 3
WT ARTE10 graph legend

Learning and Memory - Morris Water Maze

Spatial learning is impaired in cued and place learning in ARTE10 mice. No differences in working memory were found during the probe test. Reversal learning was partially impaired in ARTE10 mice.

Cued - Distance Place - Distance Reversal - Distance Probe Place - Crossings
Cued - Distance Place - Distance Reversal - Distance Probe Place - Latency to first entrance
WT ARTE10 graph legend
ARTE10 Behavioral Summary
IndicationARTE10 EffectTestSignificant
Anxiety↑Canopy TestARTE10 – increased anxiety like behaviour
Motivation/Mood↓Nest BuildingDecreased motivation/mood
Sensory Motor gating↓PPIDeficits in sensory motor gating
Activity↓LMAHypolocomotion or open field showing anxiety to enter centre
Motor FunctionNSRotarodNo motor impairments
Activity↑Running WheelHyperactive
Learning↓MWMSpatial learning deficit
MemoryNSMWMNo spatial working memory impairment

Biomarkers

Hippocampus Aβ38 Hippocampus Aβ40 Hippocampus Aβ42 Hippocampus Aβ42/Aβ40 Ratio
Cortex Aβ38 Cortex Aβ40 Cortex Aβ42 Cortex Aβ42/Aβ40 Ratio

Amyloid levels (Aβ40 and Aβ42) are increased in the cortex and hippocampus of ARTE10 animals as expected. There is a higher amyloid load in the cortex than the hippocampus at 5 months of age.

IFNγ in plasma IL-1β in plasma IL-6 in plasma TNFα in plasma

IFNγ, lL-1β, IL-6 and TNFα levels in plasma were quantified using a MSD kit. Cytokine levels are starting to increasing at this stage with trend level or significant effects in IFNγ, IL-1β and TNFα. Increased cytokines indicates increased inflammatory processes are present in the ARTE10 animals.

CSF Nfl Plasma NfL Hippocampus NfL Cortex NfL

NfL levels in plasma, CSF, hippocampus and cortex were quantified using a MSD kit. NfL is a biomarker for neuronal damage. NfL levels are trending towards an increase in the CSF of ARTE10 animals at 5 months of age. No significant changes in plasma or brain were detected.

ARTE10 Biomarker Summary
BiomarkerSample TypeSignificance
NfLPlasmaNS
CSFTrending ↑
HippocampusNS
Cortex↑
IFNγPlasmaNS
IL-1βPlasmaTrending ↑
IL-6PlasmaNS
TNFαPlasma↑
Aβ40Hippocampus↑
Cortex↑
Aβ38HippocampusNS
Cortex↑
Aβ42Hippocampus↑
Cortex↑
Aβ42/Aβ40 RatioHippocampus↑
Cortex↑

  1. Grewal S.S., Shepard J.K., Bill D.J., Fletcher, A. and Dourish C.T. 1997. Behavioural and pharmacological characterization of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology. 133:29-38
  2. Jacobson ML, Wulf HA, Tsuda MC, Browne CA, Lucki I. Sex differences in the modulation of mouse nest building behavior by kappa opioid receptor signaling. Neuropharmacology. 2020 Oct 15;177:108254. doi: 10.1016/j.neuropharm.2020.108254. Epub 2020 Jul 26. PMID: 32726598; PMCID: PMC11423493.

Company

  • Our Team
  • Publications
  • News
  • Careers
  • Animal Welfare
  • Privacy Policy
  • Accessibility Policy
  • Cookies Policy

Services

  • Abuse Liability / Substance Use Disorders
  • Alzheimer's Disease
  • Bioanalytical Studies
  • CNS Drug Disposition
  • Cognitive Assessment
  • Depression/Anxiety
  • Dermatology
  • EEG
  • Epilepsy
  • Essential Tremor
  • Imaging
  • Inflammatory Pain
  • Inflammation
  • Medical Cannabis
  • Metabolic Disorders
  • Migraine
  • Molecular Biomarkers
  • Multiple Sclerosis
  • Neuropathic Pain
  • Operant Platform
  • Osteoarthritis
  • Parkinson's Disease
  • PK/PD Studies
  • PK-Bridge
  • Psychedelics
  • PXB Mouse Studies
  • Safety Studies
  • Schizophrenia
  • Veterinary Research
North America
1-548-538-2371
Europe
+44 (0)130 440 3165
Contact us

© 2024 Transpharmation™. All Rights Reserved.
Sitemap
LinkedIn account
Youtube account